Patients in the acetaminophen-dexmedetomidine, placebo-dexmedetomidine, acetaminophen-propofol, and placebo-propofol groups were assessed for delirium on a median of 4 (interquartile range [IQR], 4-4) days, 4 (IQR, 4-5) days, 4 (IQR, 4-5) days, and 4 (IQR, 4-5) days, respectively.